FATE THERAPEUTICS INC — Investor Relations & Filings
Filings indexed
810
across all filing types
Latest filing
2026-05-13
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
FATE
Fate Therapeutics is a clinical-stage biopharmaceutical company developing programmed cellular immunotherapies for cancer and autoimmune disorders. The company utilizes its proprietary induced pluripotent stem cell (iPSC) product platform to create master iPSC lines for the mass production of universal, off-the-shelf cell products. These multiplexed-engineered cell candidates are designed with novel synthetic controls to deliver multiple therapeutic mechanisms. This approach aims to overcome key limitations inherent to other cell therapies, with the goal of making treatments more effective, routine, and accessible for patients with life-threatening diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | |
| 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | |
| DEF 14A - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-04-24 | English | |
| 10-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | |
| 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | |
| 4 Filing | 2026-01-16 | English |
Browse filings by year
18 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 45589724 | 10-Q - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | ||
| 45589249 | 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-05-13 | English | ||
| 36258782 | DEF 14A - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-04-24 | English | ||
| 32891805 | 10-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | ||
| 32891804 | 8-K - FATE THERAPEUTICS INC (0001434316) (Filer) | 2026-02-26 | English | ||
| 29759794 | 4 Filing | 2026-01-16 | English | ||
| 29759647 | 4 Filing | 2026-01-16 | English | ||
| 29759598 | 4 Filing | 2026-01-16 | English | ||
| 29759605 | 4 Filing | 2026-01-12 | English | ||
| 29759513 | 4 Filing | 2026-01-12 | English | ||
|
2025
5 filings
| |||||
| 12211721 | Regulatory Filings 2025 | 2025-12-29 | English | ||
| 12211726 | 10-Q | 2025-11-13 | English | ||
| 12211728 | 8-K | 2025-11-13 | English | ||
| 12211729 | 8-K | 2025-10-27 | English | ||
| 12211730 | 4 | 2025-10-21 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
FATE THERAPEUTICS INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34091/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34091 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34091 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34091 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34091}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FATE THERAPEUTICS INC (id: 34091)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.